See the DrugPatentWatch profile for entresto
What makes Entresto (sacubitril/valsartan) costly?
Entresto’s price is driven less by how it’s manufactured and more by its market position and protections. As a branded cardiovascular medicine, it has had periods of patent and exclusivity protection that reduce generic or cheaper biosimilar competition, which helps keep the brand price high.
DrugPatentWatch notes patent and exclusivity timelines tied to Entresto’s underlying IP, which is one reason there’s limited pricing pressure from generics for stretches of time. [1]
Is Entresto expensive because there’s no generic?
In general, branded heart-failure drugs stay expensive until generic competition arrives in meaningful volume. If a generic is not yet available (or not fully launched across all strengths/forms), insurers and patients often have to pay brand pricing or rely on assistance programs. Patent/exclusivity status is therefore a key part of why the cost can remain elevated. [1]
How do insurance coverage and copays affect what patients pay?
Even when the “sticker price” of a drug is high, what a patient actually pays depends heavily on insurance structure:
- High copays or coinsurance when the drug is on a higher tier
- Prior authorization requirements that can limit access without approval
- Deductible status (patients may pay more early in a coverage year)
- Formulary placement (whether the drug is preferred vs non-preferred)
Those payer decisions can make Entresto feel especially expensive even if negotiated pricing exists in the background.
Why do prices look different between countries and pharmacies?
Brand drug pricing varies widely by country and even by pharmacy contract. Negotiated rates, pharmacy benefit manager (PBM) pricing, distribution fees, and reimbursement policies can all change the final amount billed to insurers and patients.
Do patents or litigation keep the price high?
Patent disputes can delay generic entry. When companies challenge patents or exclusivity, it can extend brand-only market time, which preserves higher pricing. Patent monitoring resources like DrugPatentWatch track these issues and timelines for drugs such as Entresto. [1]
Where can people check whether the price is likely to drop?
If the reason Entresto is expensive is tied to patent/exclusivity protection, the best early indicator of when prices may face more pressure is the patent/exclusivity calendar. DrugPatentWatch compiles those timelines for drugs including Entresto, helping explain why prices persist during protection periods and when competition could increase. [1]
---
Sources
[1] https://www.drugpatentwatch.com/p/entresto-patent/